Laura Kaye Aguilar MD PhD
Chief Medical Officer, Diakonos Oncology
Join to View Full Profile
440 Lexington St#450Newton, MA 02466
Dr. Aguilar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1997 - 1999- Baylor College of Medicine (Houston)Residency, Pediatrics, 1994 - 1996
- Baylor College of MedicineClass of 1994
Certifications & Licensure
MA State Medical License 2001 - 2025
TX State Medical License 1995 - 2005
Publications & Presentations
PubMed
- 6 citationsPerturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma.Marilin S Koch, Mykola Zdioruk, Michal O Nowicki, Alec M Griffith, Estuardo Aguilar-Cordova
Molecular Therapy Oncolytics. 2022-09-15 - 10 citationsSystemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.Marilin S Koch, Mykola Zdioruk, Michal O Nowicki, Alec M Griffith, Estuardo Aguilar
Journal for Immunotherapy of Cancer. 2022-01-01 - 45 citationsLeveraging external data in the design and analysis of clinical trials in neuro-oncology.Rifaquat Rahman, Steffen Ventz, Jon McDunn, Bill Louv, Irmarie Reyes-Rivera
The Lancet. Oncology. 2021-10-01
Press Mentions
Diakonos Oncology Appoints Laura Aguilar, M.D., Ph.D. As Chief Medical OfficerNovember 18th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
